Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated ...

Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal ...

Customer demand and OEM innovation are driving new technology and sustainability in medium-duty trucking. Safety and ...

In one survey, 90% of consumers said that they were more likely to buy from a brand that offers eco-friendly packaging ...